Should I Buy PPBT? PPBT 2026 Analysis

Should You Buy Purple Biotech Ltd (PPBT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

0.620

1 Day change

-2.35%

52 Week Range

3.480

Analysis Updated At

2026/01/26

Purple Biotech Ltd (PPBT) is not a strong buy for a beginner, long-term investor at this time. The technical analysis shows a bearish trend, and there are no significant positive catalysts or trading signals. While the company's financial performance has improved in terms of net income, it remains unprofitable, and there is no recent news or analyst activity to support a bullish case. The options data suggests low trading sentiment, and the lack of congress trading data or influential figure activity further limits confidence in this stock as a good buy right now.

Technical Analysis

The MACD histogram is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 55.776, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 0.651, with resistance levels at 0.704 and 0.737 and support levels at 0.597 and 0.564. Overall, the technical indicators suggest a bearish trend.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

The implied volatility is high (395.05), but the put-call ratios indicate minimal trading sentiment, with very low put and call volumes.

Technical Summary

Sell

Buy

Positive Catalysts

The company's net income improved significantly YoY (96.53%), showing better cost management or operational efficiency.

Neutral/Negative Catalysts

The company remains unprofitable, with no revenue growth. There is no recent news, analyst activity, or congress trading data to support a positive outlook. Additionally, the bearish moving averages and lack of trading sentiment in options data are concerning.

Financial Performance

In Q3 2025, revenue remained at 0 with no YoY growth. Net income improved to -1,303,000, up 96.53% YoY, but the company is still unprofitable. EPS and gross margin showed no improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for PPBT.

1 Analyst Rating

Wall Street analysts forecast PPBT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PPBT is 34 USD with a low forecast of 34 USD and a high forecast of 34 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.639

Low

Averages

High